Elevated Adipocyte Membrane Phospholipid Saturation Does Not Compromise Insulin Signaling
Diabetes · 2023
DOI: 10.2337/db22-0293 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diabetes, 2023. Verfasst von Henrik Palmgren und 19 weiteren Autor:innen. Beteiligte Einrichtung: Bioscience Metabolism, Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden. Hauptthemen laut MEDLINE: Phospholipids, Insulin. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Stiftelsen för Strategisk Forskning.
Abstract (Originalsprache)
Increased saturated fatty acid (SFA) levels in membrane phospholipids have been implicated in the development of metabolic disease. Here, we tested the hypothesis that increased SFA content in cell membranes negatively impacts adipocyte insulin signaling. Preadipocyte cell models with elevated SFA levels in phospholipids were generated by disrupting the ADIPOR2 locus, which resulted in a striking twofold increase in SFA-containing phosphatidylcholines and phosphatidylethanolamines, which persisted in differentiated adipocytes. Similar changes in phospholipid composition were observed in white adipose tissues isolated from the ADIPOR2-knockout mice. The SFA levels in phospholipids could be further increased by treating ADIPOR2-deficient cells with palmitic acid and resulted in reduced membrane fluidity and endoplasmic reticulum stress in mouse and human preadipocytes. Strikingly, increased SFA levels in differentiated adipocyte phospholipids had no effect on adipocyte gene expression or insulin signaling in vitro. Similarly, increased adipocyte phospholipid saturation did not impair white adipose tissue function in vivo, even in mice fed a high-saturated fat diet at thermoneutrality. We conclude that increasing SFA levels in adipocyte phospholipids is well tolerated and does not affect adipocyte insulin signaling in vitro and in vivo.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Bioscience Metabolism, Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
- Translational Science and Experimental Medicine, Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
- Department of Chemistry and Molecular Biology, University of Gothenburg, Gothenburg, Sweden.
- Dynamic Omics, Centre for Genomics Research, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD.
- Bioscience Cardiovascular, Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
- Animal Science & Technologies, Clinical Pharmacology & Safety Sciences, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
ORCID-Profile: Marc Pilon
Förderung
- Stiftelsen för Strategisk Forskning
Zitieren
APA
Palmgren, H., Petkevicius, K., Bartesaghi, S., Ahnmark, A., Ruiz, M., Nilsson, R., Löfgren, L., Glover, M. S., Andréasson, A. C., Andersson, L., Becquart, C., Kurczy, M., Kull, B., Wallin, S., Karlsson, D., Hess, S., Maresca, M., Bohlooly-Y, M., Peng, X. R., & Pilon, M. (2023). Elevated Adipocyte Membrane Phospholipid Saturation Does Not Compromise Insulin Signaling. Diabetes. https://doi.org/10.2337/db22-0293
Vancouver
Palmgren H, Petkevicius K, Bartesaghi S, Ahnmark A, Ruiz M, Nilsson R, et al. Elevated Adipocyte Membrane Phospholipid Saturation Does Not Compromise Insulin Signaling. Diabetes. 2023. doi:10.2337/db22-0293
BibTeX
@article{Palmgren2023,
author = {Palmgren, Henrik and Petkevicius, Kasparas and Bartesaghi, Stefano and Ahnmark, Andrea and Ruiz, Mario and Nilsson, Ralf and Löfgren, Lars and Glover, Matthew S and Andréasson, Anne-Christine and Andersson, Liselotte and Becquart, Cécile and Kurczy, Michael and Kull, Bengt and Wallin, Simonetta and Karlsson, Daniel and Hess, Sonja and Maresca, Marcello and Bohlooly-Y, Mohammad and Peng, Xiao-Rong and Pilon, Marc},
title = {Elevated Adipocyte Membrane Phospholipid Saturation Does Not Compromise Insulin Signaling},
journal = {Diabetes},
year = {2023},
doi = {10.2337/db22-0293}
}
EUVIMED